| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3354 | Microtubule Inhibitor 185322 | Novel inhibitor of microtubule assembly, inducung mitotic arrest and apoptosis of MM cells |
|
| DCC3355 | Mif Degrader Md13 | Novel Potent MIF Degrader |
|
| DCC3356 | Mifamurtide | Immunomodulator, regulating the activation of monocytes and macrophages, upregulating the secretion of pro-inflammatory cytokines such as TNF-alpha, IL-1, IL-8, nitric oxide and prostaglandins E2 and D2 |
|
| DCC3357 | Mig-7 Inhibitor D-39 | Novel inhibitor of Migration-Inducting Gene 7 (MIG-7) expression, suppressing EOC cell growth and VEGFA expression |
|
| DCC3358 | Miglustat | Product Description: |
|
| DCC3359 | Milacemide Hydrochloride | MAO-B inhibitor and glycine prodrug, being studied for treatment for the symptoms of Alzheimer's disease |
|
| DCC3360 | Miliusol | Natural anti-tumor agent, demonstrating with tumor inhibitory efficacy comparable or even superior to the mainstay chemotherapeutics paclitaxel or fluorouracil |
|
| DCC3361 | Mina53-in-10 | First-in-class inhibitor of MYC-induced nuclear antigen (MINA53) with selectivity over NO66 and other JmjC oxygenases |
|
| DCC3362 | Minigastrin I (human) | Inhibitor of cholecystokinin B receptors (CCK2) |
|
| DCC3363 | Mip-1072 | Novel inhibitor of the prostate-specific membrane antigen (PSMA) |
|
| DCC3364 | Mip-1095 | Novel inhibitor of the prostate-specific membrane antigen (PSMA) |
|
| DCC3365 | Mipe-1686 | Novel long-lasting myostatin inhibitor, significantly increasing muscle mass and hindlimb grip strength in Duchenne muscular dystrophic model mice |
|
| DCC3366 | Mips1455 | Novel photoactivatable allosteric ligand for the M1 muscarinic acetylcholine receptor |
|
| DCC3367 | Mips1780 | Novel selective positive allosteric modulator (PAM) at the M1 muscarinic acetylcholine receptor |
|
| DCC3368 | Mipsagargin | Novel thapsigargin-based PSMA-activated prodrug, inhibiting the sarcoplasmic/endoplasmic reticulum calcium adenosine triphosphatase (SERCA) pump protein |
|
| DCC3369 | Mir-21 Inhibitor | Novel specific and efficient inhibitor of miR-21 expression, inducing a 485% increase in the luciferase reporter signal at 10 μM |
|
| DCC3370 | Mir-21 Inhibitor-1 | Novel inhibitor of microRNA-21 (miR-21) |
|
| DCC3371 | Miro1 Reducer | Novel Miro1 degrader, rescuing dopaminergic neurodegeneration and promoting Miro1 degradation in Parkinson’s Disease fibroblasts |
|
| DCC3372 | Miro1 Reducer 3 | Novel degrader of Miro1 (mitochondrial Rho GTPase 1), reducing Miro1 levels in fibroblasts and stress-induced degeneration of dopaminergic neurons derived from Parkinson's disease (PD) patients, as well as age-dependent neuronal loss and prolongs lifespan |
|
| DCC3373 | miroistonil | Novel inhibitor of AMA1-RON2 interaction, blocking merozoite invasion from schizont-infected RBCs; Antidepressant; Acetylcholinesterase inhibitor |
|
| DCC3374 | mitf-in-17 | The first small molecule inhibitor of Mitf-E-box DNA binding with depigmenting activity |
|
| DCC3375 | Mitobady | Sensitive and specific Raman probe for live cell imaging of mitochondria |
|
| DCC3376 | Mitodpp-2 | Fluorescent probe for measuring the activity levels of erasers of S-palmitoylation, acyl-protein thioesterases (APTs), within mitochondria of live cells |
|
| DCC3377 | Mitoebselen-2 | Radiation Mitigator, reducing lipid hydroperoxides and preventing apoptotic cell death |
|
| DCC3378 | Mitofp | Novel mitochondrial-targeted pan-APT inhibitor |
|
| DCC3379 | Mito-peg5-ato | Novel potent antiproliferative mitochondria-targeted OXPHOS inhibitor (IC50=38 nM) in MiaPaCa-2 cells, being more effective than other inhibitors of OXPHOS in MiaPaCa-2 and U87MG cells |
|
| DCC3380 | mitopy1 | Novel selective fluorescent H2O2 probe, tracking the mitochondria of live biological specimens and responds to local fluxes of hydrogen peroxide (H2O2) by a turn-on fluorescence enhancement |
|
| DCC3381 | Mitozolomide | Antineoplastic DNA alkylating agent |
|
| DCC3382 | Mizoribine Mono-phosphate | Specific inhibitor of the cellular inosine-5-monophosphate dehydrogenase (IMPDH); Immunosuppressive agent |
|
| DCC3383 | Mk0359 | Potent and selective PDE4 inhibitor |
|
